NASDAQ:CLSN
Delisted

Celsion Stock Predictions

etoro logo Buy CLSN
*Your capital is at risk
$1.56
+0.0600 (+4.00%)
At Close: Jan 27, 2023
Currently predicting for Mon, 8 Jun 2026

CLSN Prediction Chart

CLSN Predictions History

Latest community submissions for CLSN.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 10, 2017 $0.300 -93.09% $0.310 V 96.80% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CLSN with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CELSION CORPORATION
Celsion
Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company als...
GOLDEN STAR
Ticker Change Signal Date
FISV
0% Nov 30
K
KEEL
0% Nov 30
D
DFTX
0% Nov 30
R
RKLZ
0% Nov 30
R
RKTO
0% Nov 30

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE